ReNu with MoistureLoc Recall Lawsuit & Investigation

Multi-Purpose Contact Lens Solution Linked to Eye Infections

Send to Friend | Bookmark | Live Chat

The popular multi-purpose contact lens solution ReNu with MoistureLoc has been linked to Fusarium Keratitis, Microbial Keratitis and fungal eye infections.

UPDATE: Our firm is also investigating a possible link between ReNu with MoistureLoc and the development of another form of corneal infections (keratitis), caused by acanthaoemeba -- Acanthamoeba Keratitis.

Keratitis Eye Infection Update

The U.S. Centers for Disease Control & Prevention (CDC) and the U.S. Food & Drug Administration (FDA) are investigating a link between the AMO Complete® MoisturePlus™ Multi-Purpose Solution and 138 confirmed cases of Acanthamoeba Keratitis, another rare form of Keratitis, which is described as a painful eye infection that can lead to permanent vision loss or blindness.

The aforementioned investigation has led to a nationwide recall of the multi-purpose contact lens solution Complete® MoisturePlus™.

Our Investigation: Our firm is investigating a possible link between corneal eye infections (keratitis) and other multi-purpose contact lens solutions including but not limited to ReNu with MoistureLoc & ReNu MultiPlus (Bausch & Lomb), Opti-Free (Alcon), SOLO-care (Ciba Vision), and Complete® MoisturePlus™ Multi-Purpose Solution (Advanced Medical Optics).

If you or a loved one have developed a corneal infection (keratitis) while using any multi-purpose contact lens solution, you should contact us immediately. You may be entitled to compensation.

Talk to your doctor: Acanthamoeba Keratitis is often misdiagnosed, and/or confused with other forms of keratitis caused by bacteria, fungus or viruses such as herpes. If you have developed a corneal infection that has not responded well to treatment, you may want to ask your doctor to consider acanthamoeba.

FDA ReNu with MoistureLoc Fusarium Keratitis Warning

In a preliminary public health notification dated April 10, 2006, the Food and Drug Administration issued a warning related to a number of reports in the United States of a rare but serious fungus infection of the eye in soft contact lens wearers. More specifically, the infection (fungal keratitis) caused by the Fusarium fungus, may cause vision loss requiring corneal transplants.

Both the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) are investigating this situation and have been notified by Bausch and Lomb that they have agreed to stop the shipping of their popular ReNu MoistureLoc brand contact lens solution.

U.S. Centers for Disease Control & Prevention (CDC) Statement on Outbreak

The CDC stated that it received reports of 109 cases of suspected fungal keratitis in 17 different states. Twenty-eight of the 30 wore soft contact lenses. Preliminary information obtained by CDC from patient interviews indicates that 26 of these patients remembered which products they used, and that all 26 reported using a Bausch & Lomb ReNu brand contact lens solution in the month prior to the onset of infection. Patients reported using a variety of different ReNu types from multiple different product lots. Five of the patients reported using other solutions in addition to the ReNu product. Strain typing of the organism is ongoing.

Do I have a ReNu with MoistureLoc Eye Infection Lawsuit?

The Products Liability Litigation Group at our law firm is an experienced team of trial lawyers that focus exclusively on the representation of plaintiffs in ReNu with MoistureLoc recall lawsuits. We are handling individual litigation nationwide and currently accepting new Renu Recall cases in all 50 states.

Attention Attorneys: We do not publish prior verdict/settlements. If you are an attorney and would like to refer us a case or for us to send you a profile of prior award judgments or average referral fees, please visit the attorney referral section of our website.

= Required Field

ReNu with MoistureLoc Recall News (National)

Victim of Faulty Contact Lens Solution Relates Horror of Infection to FDA Panel
Santa Ana, CA June 17, 2008 -- Michael E. Schmidt & Thomas M. Moore address FDA Panel ... their law firms represents dozens of Acanthamoeba victims in litigation against Advanced Medical, the maker of Complete® MoisturePlus™ ... the attorneys encouraged the FDA to require solutions to be effective against Acanthamoeba and to make manufacturers clearly warn about the risk of infection.

Multiple Lawsuits Filed Over Recalled Contact Lens Solution
Santa Ana, CA July 30, 2007 -- Four more products liability lawsuits were filed yesterday against the manufacturer of Complete® MoisturePlus™ contact lens solution in Orange County Superior Court in Santa Ana, California. The product was voluntarily recalled on May 25 at the request of the Food & Drug Administration in the wake of data collected and reviewed by the Centers for Disease Control linking the solution to a serious corneal infection known as Acanthamoeba keratitis. The new cases add to a growing number of injury and class action claims arising out of the recall.

Schmidt & Clark Represents Plaintiff in First U.S. Products Liability Case on Recalled Contact Lens Solution
Santa Ana, CA June 4, 2007— The Dallas-based law firm Schmidt & Clark announced today that it represents a Southern California couple in what is believed to be the first personal injury lawsuit brought against the manufacturers of Complete® MoisturePlus™ contact lens solution since the product was voluntarily recalled on May 25 at the request of the Food & Drug Administration...

First U.S. Consumer Class Action Filed Against Advanced Medical Optics, Inc. for Recently Recalled Contact Lens Solution Complete® MoisturePlus™
Santa Ana, CA June 8, 2007 — What is believed to be the first class action lawsuit brought in the United States against the manufacturer of Complete® MoisturePlus™ contact lens solution was filed today in Orange County Superior Court in Santa Ana, California.  The product was voluntarily recalled on May 25 at the request of the Food & Drug Administration in the wake of reports of an association between the solution and serious corneal infections...